Nagaraju GP - Search Results

1

Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer.

Zhang Y, Ware MB, Zaidi MY, Ruggieri AN, Olson BM, Komar H, Farren MR, Nagaraju GP, Zhang C, Chen Z, Sarmiento JM, Ahmed R, Maithel SK, El-Rayes BF, Lesinski GB. Zhang Y, et al. Among authors: nagaraju gp. Mol Cancer Ther. 2021 Jan;20(1):150-160. doi: 10.1158/1535-7163.MCT-19-0911. Epub 2020 Oct 9. Mol Cancer Ther. 2021. PMID: 33037138 Free PMC article.

2

Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma.

Zafar SF, Nagaraju GP, El-Rayes B. Zafar SF, et al. Among authors: nagaraju gp. Expert Opin Ther Targets. 2012 Jul;16(7):707-18. doi: 10.1517/14728222.2012.691473. Epub 2012 May 24. Expert Opin Ther Targets. 2012. PMID: 22621256 Review.

3

The impact of curcumin on breast cancer.

Nagaraju GP, Aliya S, Zafar SF, Basha R, Diaz R, El-Rayes BF. Nagaraju GP, et al. Integr Biol (Camb). 2012 Sep;4(9):996-1007. doi: 10.1039/c2ib20088k. Epub 2012 Jul 6. Integr Biol (Camb). 2012. PMID: 22772921 Review.

4

SPARC and DNA methylation: possible diagnostic and therapeutic implications in gastrointestinal cancers.

Nagaraju GP, El-Rayes BF. Nagaraju GP, et al. Cancer Lett. 2013 Jan 1;328(1):10-7. doi: 10.1016/j.canlet.2012.08.028. Epub 2012 Aug 29. Cancer Lett. 2013. PMID: 22939997 Review.

5

Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.

Nagaraju GP, Park W, Wen J, Mahaseth H, Landry J, Farris AB, Willingham F, Sullivan PS, Proia DA, El-Hariry I, Taliaferro-Smith L, Diaz R, El-Rayes BF. Nagaraju GP, et al. Angiogenesis. 2013 Oct;16(4):903-17. doi: 10.1007/s10456-013-9364-7. Epub 2013 Jul 10. Angiogenesis. 2013. PMID: 23838996

6

Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases.

Nagaraju GP, Zafar SF, El-Rayes BF. Nagaraju GP, et al. Nutr Rev. 2013 Aug;71(8):562-72. doi: 10.1111/nure.12044. Epub 2013 Jun 24. Nutr Rev. 2013. PMID: 23865800 Review.

7

Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer.

Nagaraju GP, Zhu S, Wen J, Farris AB, Adsay VN, Diaz R, Snyder JP, Mamoru S, El-Rayes BF. Nagaraju GP, et al. Cancer Lett. 2013 Dec 1;341(2):195-203. doi: 10.1016/j.canlet.2013.08.002. Epub 2013 Aug 7. Cancer Lett. 2013. PMID: 23933177

8

Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3 mesoporous particles.

Seeta Rama Raju G, Pavitra E, Nagaraju GP, Ramesh K, El-Rayes BF, Yu JS. Seeta Rama Raju G, et al. Among authors: nagaraju gp. Dalton Trans. 2014 Feb 28;43(8):3330-8. doi: 10.1039/c3dt52692e. Dalton Trans. 2014. PMID: 24366050

9

CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.

Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS. Colbert LE, et al. Among authors: nagaraju gp. Cancer Res. 2014 May 15;74(10):2677-87. doi: 10.1158/0008-5472.CAN-13-1996. Epub 2014 Mar 13. Cancer Res. 2014. PMID: 24626090 Free PMC article.

10

Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.

Nagaraju GP, Dontula R, El-Rayes BF, Lakka SS. Nagaraju GP, et al. Carcinogenesis. 2014 May;35(5):967-73. doi: 10.1093/carcin/bgu072. Epub 2014 Mar 27. Carcinogenesis. 2014. PMID: 24675529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters